Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Rehab E. Abo El gheit. (2017) Effect of the renal natriuretic peptide, ularitide, alone or combined with Vasopeptidase inhibitor, Omapatrilat, on experimental volume overload-induced congestive heart failure in rats (Ularitide/Omapatrilat in Congestive Heart Failure). Alexandria Journal of Medicine 53:2, pages 135-149.
Read now
Read now
Julian Segura, Jorge Salazar & Luis M Ruilope. (2013) Dual neurohormonal intervention in CV disease: angiotensin receptor and Neprilysin inhibition. Expert Opinion on Investigational Drugs 22:7, pages 915-925.
Read now
Read now
Nelly Blaes & Jean-Pierre Girolami. (2013) Targeting the ‘Janus face' of the B2-bradykinin receptor. Expert Opinion on Therapeutic Targets 17:10, pages 1145-1166.
Read now
Read now
Adriaan A Voors, Bernard Dorhout & Peter van der Meer. (2013) The potential role of valsartan + AHU377 (LCZ696) in the treatment of heart failure. Expert Opinion on Investigational Drugs 22:8, pages 1041-1047.
Read now
Read now
Alberto R De Caterina, Andrew R Harper & Florim Cuculi. (2012) Critical evaluation of the efficacy and tolerability of azilsartan. Vascular Health and Risk Management 8, pages 299-305.
Read now
Read now
Agata Bielecka-Dabrowa, Jacek Rysz, Dimitri P Mikhailidis & Maciej Banach. (2011) What is the risk of hyperkalaemia in heart failure?. Expert Opinion on Pharmacotherapy 12:15, pages 2329-2338.
Read now
Read now
Articles from other publishers (12)
Speranza Rubattu, Maria Cotugno, Maurizio Forte, Rosita Stanzione, Franca Bianchi, Michele Madonna, Simona Marchitti & Massimo Volpe. (2018) Effects of dual angiotensin type 1 receptor/neprilysin inhibition vs. angiotensin type 1 receptor inhibition on target organ injury in the stroke-prone spontaneously hypertensive rat. Journal of Hypertension 36:9, pages 1902-1914.
Crossref
Crossref
Charmaine C. W. Lo, Seyed M. Moosavi & Kristen J. Bubb. (2018) The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension. Frontiers in Physiology 9.
Crossref
Crossref
Wenke Schmedt auf der Günne, Yi Zhao, Jürgen Hedderich, Peter Gohlke & Juraj Culman. (2015) Omapatrilat: penetration across the blood–brain barrier and effects on ischaemic stroke in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 388:9, pages 939-951.
Crossref
Crossref
Elie R Chemaly, Roger J Hajjar & Larissa Lipskaia. (2013) Molecular targets of current and prospective heart failure therapies. Heart 99:14, pages 992-1003.
Crossref
Crossref
Raffaella D’Alessandro, Daniele Masarone, Andrea Buono, Rita Gravino, Alessandra Rea, Gemma Salerno, Enrica Golia, Ernesto Ammendola, Giuseppe Del Giorno, Lucio Santangelo, Maria Giovanna Russo, Raffaele Calabrò, Eduardo Bossone, Giuseppe Pacileo & Giuseppe Limongelli. (2013) Natriuretic peptides: molecular biology, pathophysiology and clinical implications for the cardiologist. Future Cardiology 9:4, pages 519-534.
Crossref
Crossref
Ross D. Feldman & Eric P. Brass. (2013) From Bad Behaviour to Bad Biology: Pitfalls and Promises in the Management of Resistant Hypertension. Canadian Journal of Cardiology 29:5, pages 549-556.
Crossref
Crossref
Harrina E. Rahardjo, Stefan Ückert, Akmal Taher, Joachim E. Sonnenberg, Wolfgang Kauffels, Djoko Rahardjo & Markus A. Kuczyk. (2013) Effects of Endopeptidase Inhibition on the Contraction–Relaxation Response of Isolated Human Vaginal Tissue. The Journal of Sexual Medicine 10:4, pages 951-959.
Crossref
Crossref
William J. Elliott. 2013. Hypertension: A Companion to Braunwald’s Heart Disease. Hypertension: A Companion to Braunwald’s Heart Disease
226
229
.
Björn Maul, Matthias Becker, Florian Gembardt, Axel Becker, Heinz-Peter Schultheiss, Wolf-Eberhard Siems & Thomas Walther. (2012) Genetic Deficiency in Neprilysin or Its Pharmacological Inhibition Initiate Excessive Stress-Induced Alcohol Consumption in Mice. PLoS ONE 7:11, pages e50187.
Crossref
Crossref
Christoph Birner, Coskun Ulucan, Mona Bratfisch, Tobias Götz, Alexander Dietl, Frank Schweda, Günter A. Riegger & Andreas Luchner. (2012) Antihypertrophic effects of combined inhibition of the renin–angiotensin system (RAS) and neutral endopeptidase (NEP) in progressive, tachycardia-induced experimental heart failure. Naunyn-Schmiedeberg's Archives of Pharmacology 385:11, pages 1117-1125.
Crossref
Crossref
Domenico Regoli, Gerard E. Plante & Fernand Gobeiljr.jr.. (2012) Impact of kinins in the treatment of cardiovascular diseases. Pharmacology & Therapeutics 135:1, pages 94-111.
Crossref
Crossref
Camilla Calvieri, Speranza Rubattu & Massimo Volpe. (2011) Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides. Journal of Molecular Medicine 90:1, pages 5-13.
Crossref
Crossref